CA
NZ
UK
AU
IND
US
Net revenues were USD 13,991 thousand, compared with USD 10,112 thousand in the third quarter of 2025. Cost of revenues, exclusive of amortization of intangible assets, was USD 8,486 thousand versus USD 6,281 thousand. For the nine months ended September 30, 2026, net revenues …
On a same-store basis, covering 35 properties and 12,980 units, NOI fell 8.2% to USD 35.6 million from USD 38.8 million. TotalRevenuedeclined 0.7%, occupancy fell 70 basis points and average effective rent fell 0.7%. For the nine months, same-store revenue fell 1.2% and NOI …
The company issued 4.7 million common shares in the quarter for gross proceeds of USD 234 million. Chief Executive Officer Matthew Gourmand said the company again grew funds available for distribution per share while reducingLeverageto the lowest level in its history, and that operator …
Net income attributable to the company fell to USD 1.1 million, or USD 0.04 per diluted share, from USD 10.5 million, or USD 0.48. The company attributes the drop principally to an USD 887,000 net gain on real estate sales in the quarter versus …
Net income was USD 22.9 million, or USD 0.45 per diluted share, versus USD 5.2 million, or USD 0.11. AdjustedNet Incomewas USD 26 million, up 38% from USD 19 million, and adjusted EPS was USD 0.51 versus USD 0.39. Adjusted EBITDA rose 37% to …
Cost of revenue was USD 34,066 thousand versus USD 22,866 thousand, and gross profit was USD 25,259 thousand versus USD 16,659 thousand. For the nine months ended September 30, 2026, total revenue was USD 162,529 thousand versus USD 107,206 thousand, and gross profit was …
Upstream product revenues were USD 2,211 million versus USD 1,722 million, and service revenues were USD 4 million versus USD 9 million. Total product and service revenues were USD 2,215 million versus USD 1,731 million. Sales of purchased product were USD 343 million versus …
Patient and resident service revenue was USD 1,498,137 thousand versus USD 1,344,302 thousand, and other revenues were USD 441 thousand versus USD 265 thousand. For the nine months ended September 30, 2026, total revenue was USD 4,347,070 thousand versus USD 3,930,953 thousand, and patient …
GAAP gross margin was 80% and non-GAAP gross margin was 84%.Gross Profitwas USD 323.6 million. Operating expenses rose to USD 330.8 million from USD 285.1 million, withResearch and Developmentat USD 108.5 million against USD 88.0 million and general and administrative at USD 72.3 million …
Group adjusted EBITA margin increased by 70 basis points year over year to 13%, driven by higher sales, improved gross margin, a growing contribution from higher-margin innovations and productivity delivery, with a modest benefit from more favorableTariffrates. Adjusted EPS increased more than 10% year …
Please wait processing your request...